Adam Auvil - Director, FP&A Ed Bonach - Chief Executive Officer Scott Perry - Chief Business Officer Erik Helding - Treasurer and Head of Investor Relations

Randy Binner - FBR Capital Markets Erik Bass - Citigroup Ryan Krueger - KBW Humphrey Lee - Dowling Partners Dan Bergman - UBS Tom Gallagher - Credit Suisse

Good morning, and thank you for joining us on CNO Financial Group's third quarter 2015 earnings conference call. Today's presentation will include remarks from Ed Bonach, Chief Executive Officer; Scott Perry, Chief Business Officer; and Erik Helding, Treasurer and Head of Investor Relations.

Following the presentation, we will also have several other business leaders available for the question-and-answer period. During this conference call, we will be referring to information contained in yesterday's press release.

You can obtain the release by visiting the media section of our website at www.cnoinc.com. This morning's presentation is also available in the Investors section of our website and was filed in a Form 8-K earlier today.

We expect to file our Form 10-Q and post it on our website by November 3. Let me remind you that any forward-looking statements we make today are subject to a number of factors which may cause actual results to be materially different than those contemplated by the forward-looking statements.

Today's presentation contains a number of non-GAAP measures, which should not be considered as substitutes for the most directly comparable GAAP measures. You will find a reconciliation of the non-GAAP measures to the corresponding GAAP measures in the appendix.

Throughout this presentation, we will be making performance comparisons and unless otherwise specified, any comparisons made will be referring to changes between the third quarter 2014 and third quarter 2015. And with that, I'll turn the call over to Ed.

Thanks, Adam, and good morning everyone. CNO had another good quarter as we continue to expand our customer reach and recorded growth in several key measures.

NAP was up 1% on a consolidated basis while sales of third-party products which are not included in NAP were up 10%. On a policy issued bases sales were up 3% and our overall policies in force grew by 1%.

Collected premium growth was robust, up 7% driven by a rebound in annuity sales which also drove a 2% in annuity account values. Growing the franchise not only through sales but also retaining satisfied customers.

Operating earnings per share excluding significant items were $0.33, up 3% over the prior year. We continue to experience strong margins in most of our businesses and our supplemental health results stabilized.

It's important to note that earnings in the third quarter of 2014 were particularly strong as we experienced outsized favor ability in both, mortality and morbidity. We continue our solid track record of returning capital to shareholders.

During the quarter, we bought back $124 million of common stock and paid $13 million in common stock dividends. Lastly, we reached another significant milestone on the ratings front, in achieving an A.M.

Best A minus financial strength rating. We expect this to favorably impact our businesses, especially our Washington National work site business.

With that I'll now turn it over to Scott to discuss our segment results.

Thanks, Ed. Beginning with Bankers Life, production in the quarter was mixed.

NAP was $59.9 million, it was down 3%, primarily due to lower life insurance sales. While the number of new life insurance policies issued has grown this year, average issued premium has been lower resulting in lower NAP for the product line.

We experienced strong growth and annuity sales driven by higher demand of our fixed index annuity products. These contracts resonate well with those at/or near retirement as they blend protection of principle with the potential for account growth.

Sales of third-party products, primarily Medicare advantage plans continues to experience strong consumer demand. Policies were sold were up 10%.

Fee income generated by these sales on the trailing four quarter basis was $16.6 million, up 16% over last year. This is important non-life income enables us to more fully utilize our valuable NOLs.

Average producing agents was down slightly driven by recruiting shortfall. After three consecutive quarters of recruiting gains, our July results were particularly weak and this resulted in a 19% decline in the number of new contracts.

On a year-to-date basis, recruiting is down just slightly over the prior year. We recently rolled out a new applicant tracking system and recruiting activity has increased from July levels.

Given our year-to-date results we currently expect Bankers Life's full year NAP to come in at the low end of our guidance range or flat to down 3%. Lastly, collected premiums were up 6%, primarily driven by the increase in annuity sales.

Turning to Washington National, sales were up 1% in the quarter. Work site sales were up 10% with strong growth in supplemental health and life insurance in the work site market driven by PMA, our wholly-owned marketing organization.

Individual market sales were down 3%, this compared to an especially strong quarter of performance in the prior year. Average producing agents at PMA remains robust and was up 7%.

We anticipate Washington National sales growth to be near the low end of our previous guidance of 3% to 5% in 2015 with momentum in work site sales offset by slower individual market sales growth. Lastly, sales growth and strong persistency contributed to a 9% increase in Washington National supplemental health collected premium.

As we look beyond 2015, we expect continued progress in the work site marketplace assisted by the A.M. Best upgrade as Ed mentioned earlier.

The upgrade allows us to now compete for business opportunities that have historically been more rating sensitive. Moving to Slide 8, Colonial Penn posted 15% sales growth and is up 18% on a year-to-date basis.

The continued positive results are driven by strong direct mail and web digital generated activities, continued marketing cost effectiveness, and higher sales productivity. We are currently expecting Colonial Penn full year sales growth to be near the high end of the 12% to 15% guidance range.

Collected premiums were up 8% due to continued growth in the block. Third quarter EBIT was slightly positive and is currently running just below breakeven for the year as we decreased advertising spend in the fourth quarter and project growth and enforce earnings.

We continue to expect Colonial Penn's EBIT to be in the $3 million to $6 million dollar range for the year. Before I turn it over Erik, I'd like to make a few comments about the investments we are making in the businesses.

The strong growth results we are seeing at Colonial Penn over the last six quarters reflect the successful execution of investments made over the last three to four years. Some of these investments like our CRM system required lengthy implementation schedules but are now paying off in significant productivity improvements of our telesales organization.

During late 2014 and throughout 2015, we have been investing in growth and productivity initiatives at Bankers Life and Washington National. We expect most of the heavy lifting to be complete by the early part of next year, and sales and productivity improvements to follow.

We are focused on moving quickly to begin to reap the benefit of these important investments that better position us for future growth. I'll now turn it over to Erik to discuss CNO's financial results.

Thanks, Scott. CNO posted another good quarter on the earnings and capital front.

Adjusting for the one significant item in the period we recorded operating earnings of $0.33 per share, an increase of 3% over last year. Normalized operating ROE was 8.7%, relatively flat compared to last year but as Ed mentioned, third quarter 2014 results were unusually strong and marked by significant mortality and morbidity outperformance.

Third quarter 2015 results were largely in line with expectations, although we did experience some volatility in our corporate segment results due to equity market performance. As Scott noted, results of the Colonial Penn continue to be strong.

While Colonial Penn's earnings in the period did not materially contribute to EPS or ROE, it's important to note that the continued growth in enforce like Colonial Penn is creating real long-term value for shareholders. Our capital position remains strong with estimated consolidated risk-based capital of 440%.

Leverage was 20.2%, and holding company liquidity was $354 million. We repurchased $124 million of common stock in the quarter and $311 million on a year-to-date basis, well on our way to our repurchase guidance range of $350 million to $425 million for the year.

We are tactical and opportunistic in our repurchases, so where we ultimately end up within the range will depend on share price performance over the remainder of the year. Turning to Slide 10 in our normalized segment earnings, Bankers Life posted EBIT of $79.8 million in the quarter.

Down from the prior year but as noted, this is largely due to significant mortality and morbidity outperformance in the prior year. Current period results were largely in line with expectations although we did experience moderately higher Medicare supplement claims and lower levels of call prepayment income.

Washington National reported earnings of $30.6 million, up slightly from the prior year. Benefit ratios in our supplemental health business stabilized in the quarter, a good result coming off a couple of quarters of volatility.

Colonial Penn reported slightly positive earnings in line with seasonal expectations. Sales and earnings results continue to benefit from marketing productivity gains and lead generation diversification.

Excluding the impact of equity market volatility corporate segment earnings were generally in line with expectations. Turning to Slide 11, as I mentioned we experienced moderately elevated level of claims in our Bankers Life Medicare supplement block and recorded a benefit ratio of 71.5%.

Performance over the past several quarters has been particularly strong, and as such we don't view the current period results as unusual, more just a reversion to longer term expectations. On a year-to-date basis, our Medicare supplement benefit ratio is 69.2%.

We continue to expect this benefit ratio to be in 70% for the fourth quarter. Our long-term care interest adjusted benefit ratio came in just under 84% for the quarter, in line with expectations and we expect to continue stability in the fourth quarter.

Washington National supplemental health interest adjusted benefit ratio came in at 57.4%, in line with expectations. And current claims have stabilized and we continue to expect this ratio to be in the 58% range for the fourth quarter.

Turning to Slide 12 and investment results. We continue our tactical approach to investing new money.

We put money to work at 5.21% for the quarter, slightly above the second quarter as market volatility resulted in wider spreads for a period of time. After a couple of quarters of elevated call prepayment income, third quarter results moderated some.

Overall, credit conditions remain favorable and net realized gains and losses continue to be low. Impairments in the quarter were slightly higher but due primarily to selected names in the energy sector in Puerto Rico.

Before I turn the call back over to Ed, let me provide a brief update on our Bankers Life long-term care business. As discussed in our second quarter earnings call, we recently commenced a new round of rate increases.

We continue to run ahead of expectations and expect to have all initial filings completed by the end of the first quarter of 2016. Claims experienced for the first nine months of the year has been largely in line with expectations, and as such it's unlikely that we would see any material impact at testing margins related to this assumption.

We continue to build our future loss reserve and increased our accrual in 2015. While this negatively impact short-term earnings, the increased accrual contributes to testing margins and helps defend our balance sheet from potential future charges.

Continued low interest rates are a challenge and put pressure on margins. The amount of potential deterioration will depend on the assumed recovery of interest rates, as well as the project at ultimate rate.

If you recall from our 2014 loss recognition testing results, we pushed out the rate of recovery by one year and also decreased the ultimate rate by 50 basis points. The combination of these changes resulted in a $50 million decrease to margin.

If we were to leave the ultimate rate assumption unchanged, the impact on margins from pushing up the recovery rate by one year would be closer to $15 million. While it is still early and we need to go through the formal testing process and update all assumptions, based on current trends we anticipate year-end 2015 loss recognition testing margins for our Bankers Life long-term care business to improve modestly.

I'll now turn it back over to Ed for some closing comments.

Thanks, Erik. As Scott mentioned, we have been and continue to make investments to strengthen the foundation of our business.

We are at different stages of these investment with initiatives that started several years ago at Colonial Penn yielding results today and initiatives currently underway at Bankers Life and Washington National expected to generate profitable sales growth in 2016 and beyond. We continue to explore options to reduce our long-term care exposure by roughly half on a relative basis over the next four to seven years.

As previously discussed this will occur through a combination of runoff of the older and more comprehensive policies, increase sales of other lines of business and reinsurance of LTC. The search for our new Chief Financial Officer is progressing and we expect to be in the position to have a candidate selected by the time we were report fourth quarter earnings.

Lastly, we expect to provide 2016 guidance on sales, key earnings drivers and capital deployment as part of our fourth quarter earnings call. And with that we'll now open it up for questions.

Operator? Jennifer?

Operator?

Good morning, thank you. I just wanted to kind of start at the end there with some of the long-term care comments.

The first was for Erik, the - I think you are saying overall, the loss recognition testing margins should have a modest improvement. That includes kind of understanding where yields are now?

And the reason I asked it that way as I think that you needed the new money yields to stay more unlike the 5.50% or better range on basis points. And I think you just said you have 5.21%.

So am I understanding your comments correctly that the good guys in everything else are offsetting that continued bad guy with low reinvestment yields?

Hi Randy, it's Erik. So just to clarify, our new money rate assumption for the long-term care business, that was set for 2014 loss recognition testing purposes was 5.50 for 2015 and then increased to 6% in 2015 and then 6.50% was the ultimate rate.

That's slightly different than the 5.21% that we talked about on the investment slide that is the aggregate new money rate for the company. So the 5.50% for this year is specific to long-term care.

The comments with respect to margin and potential margin improvement for this year, yes they were meant to be all inclusive and include potential deterioration related to long-term care. So you'll note that we framed up sort of the potential for margin deterioration in terms of what happened last year where we pushed out the rate of recovery by one year and then also decreased the ultimate rate by 50 basis points, that resulted in $50 million of margin deterioration.

So that could happen again this year, alternatively we could lead the assumption unchanged and that will obviously result in no margin deterioration. A third scenario would be that we just push out the rate of recovery and leave the ultimate rate unchanged, and that was the $15 million deterioration that I talked about that.

Does that help?

Okay, understood. It does.

Sorry Randy, this is Ed. One thing I'll add to what Erik said, going back to the 5.21% new money rate that we have achieved here this year.

That as Erik said was the aggregate for all lines of business with a positively sloping yield curve which we've had and long-term care being our longest duration liabilities. The new money yield on long-term care is higher than 5.21%, we haven't disclosed specifically what it is but it is higher than 5.21%.

Got it. Okay, that is helpful.

And then, I guess just to kind of a more important question - I'm sorry, one more on long-term care. Ed, you mentioned that reinsurance continues to be a goal.

There was a transaction that was notable in kind of the riskier area of life insurance market, recently with NASA [ph] and Phoenix. So, to me that implies that a lot of things are possible.

How would you characterize the market as you talk to counter parties around a potential risk transfer?

I would summarize it as it is a viable market, there is a good mix of players meaning traditional longstanding reinsurers, all the way to some newer entrants backed by private equity, there are players that have done transactions in the LTC space. And with that I think we continue to believe and experience that our long-term care business, given the less duration than most books in the industry, given the stability of the business, the lower average benefits with less than 5% having any type of lifetime benefits.

And the vast majority of our products having less than four years of benefits, it's kind of book of business that the potential bid ask is likely to be narrower. So that would seem to indicate there is an opportunity to do a transaction or transactions but we're obviously not at that point to have something in hand or announced.

Great. And I just wanted to get one more, in fact the model, I think I picked up somewhere, the comment was that the Medicare sub benefit ratio and Bankers - you'd expect that to be higher through the fourth quarter this year or it's just higher like more like this, kind of above 70% level going out for a while?

Hi Randy, it's Erik again. Now for the fourth quarter we expect the Meds up benefit ratio to be 70%.

Okay, so 70% and then it kind of stabilizing around 70% going forward or - because that would be well normal.

As I'd mentioned, we are little early in the process and we'll be providing outlook for 2016 on our fourth quarter call.

I just wanted to touch on a couple of things for long-term care. You mentioned obviously some of the favorable items that could benefit the reserve margin when you do your fourth quarter review.

Do you expect to recognize the full benefit of better rate experience in the claims management initiatives that you've undertaken in 2015 or is that something where you'd see a partial benefit this year and then there would be a potential for further benefit in 2016? And I guess secondly given the potential for the improvement in margins, would you contemplate any changes to the level of the future loss reserve accrual for 2016?

Erik, this is Erik. So with respect to rate increase assumptions, so obviously as we progress through the process and make our way through year-end loss recognition testing assumptions, we will update our rate increases assumptions including success factors.

So I'm not sure if the angle of your question was what would reflect a 100% success factor or something more than 40% which was in our current assumptions. But the idea is if we continue to run favorable it would be something more than 40% success factor.

Second part of the question on claims management initiative; we talked about earlier in the year a potential benefit of roughly $100 million contributing to margin. We don't expect to recognize all of that here for year-end 2015 testing purposes, more just a portion with potential benefits out in 2016 and 2017.

Does that answer your question?

[Indiscernible] I was cut-off. But I just wanted to follow-up I guess maybe on what Erik was just asking.

On the - because the future loss reserve is some of a newer mechanism than I'm used to. Is that something that - if claims experience was pretty consistent with your expectations in long-term care, should we expect the benefit ratio to generally remain stable or would that may cause somewhat of an increase overtime, just kind of naturally as that falls through?

Ryan, it's Erik again, and operator if you could please check the logistics on your side, it appears that the analysts are being cut-off, if we could avoid that going forward that would be much appreciated, and I apologize for that everybody on the phone. So to answer your question, so the build in the FLR, could that come down or could that go up.

It depends on what happens with respect to your own loss recognition testing. So it may change, so if things work favorably and we build margin that may reduce the future loss reserve accrual on a go forward basis, it may not though, it depends.

And then with respect to - will the benefit ratio overtime go down? Not likely, this is - what's going to happen is as we make our way through the rate increase process, we will likely start to see elevated shock lapses which would have the effect of reducing the benefit ratio in the near time but over the long range we expect the benefit ratio to be in this range if not slightly increase over a longer period of time due to aging.

Yes, the other thing Ryan I'll add to what Erik said is, on the shock lapses - recall that we will not have all of the shock laps reserve go into earnings, we will take half of that and put it into the FLR. So, that will also impact the future FLR build but to what extent again is to be determined depending on what degree of shock lapses we have.

Okay. But just to make sure I understood correctly.

Just you would accept potentially some modest increase overtime in the benefit ratio just naturally as the book ages, is that the right way to think about it?

Yes, that's correct.

Okay. And then shifting to sales, can you give a little bit more perspective on I guess what exactly drove the big drop-off in bankers recruiting and what you did to try to correct that going forward?

Sure Ryan, this is Scott. First of all, as I've pointed out in the call, we - my comments, we did have three consecutive strong quarters.

We had a strong quarter, the second quarter of this year, some of that - we accelerated some activity that would normally have fallen into July, we didn't really have good visibility into that. And we had - our pipeline was reducing, it was getting a little soft.

One of the things that we've done to avoid this and it caused really a very soft July as I mentioned and we started to see some recovery in August and September. One of the things we've done in the quarter we introduced a new applicant tracking system this has been coming for a while but it was fully implemented up and running starting in beginning this quarter.

That system besides doing a lot of other things will give us good visibility into the pipeline, so we can get in front of this sooner. And it's just getting more recruits into the process, and into the flow.

So, we - that's what we did to mitigate this going forward and then we can take action around that if we see either our schedules or our shows which are people coming to our career briefing slowing down. So the main action we took was to fully implement and get everybody up and trained in the field, utilizing the new applicant tracking system.

Okay, thank you.

Maybe to follow-up on the question Ryan was just asking. I mean, is there anything in terms of the competition for recruits that has changed or I guess now it's been a struggle little bit to grow the Banker's agent count for the past year or so.

And you've mentioned some - that the competitors are being more competitive and copying some of your recruiting tactics, anything going on there? So I guess, just any thoughts around that.

I don't think there has been any change I'd say, just consistency. And I've also mentioned in the past that it has - as the economy improves and the job market gets better, it affects - it further pressures recruiting into straight commission roles.

So I wouldn't say that we've seen any changes but those factors continue to be headwinds. Recruiting is always and will continue to be a focus of the banker's field and we're certainly looking for ways to improve our results, both in the volume of candidates and the quality of those candidates.

I think it's important to remember that the way we intend to grow the agency force is through a combination of new recruits and the retention of our base force. And you retain your base force by driving productivity improvements, and we expect those two things combined and we're doing a number of things we've talked about the past around salesforce automation and lead generation tactics to support the productivity of the base force.

And we expect a combination of those things that will allow us to grow our agency force. But certainly, the headwinds we're seeing in recruiting continue and will need to continue, and we'll continue to look for ways to improve our effectiveness.

Got it. And can you remind us what your plans are in terms of opening new branches or locations for bankers and how many of those have been opened year-to-date?

So I don't have the year-to-date number in front of me, we're standing at about 315 locations and were pretty comfortable with that number. We don't have any purposeful plans and we will be looking in that more opportunistically.

And as we open we also close given dynamics that are going on in a particular local market. So I think our strategy around that is more to digest the expansion that has taken place over the last three years.

And then look up opportunistically for new locations where we have the market opportunity and the talent to staff that office.

Got it. Is that a change from your approach previously when you talked about - sort of opening 10 to 20 branches - not branches but locations, per year.

Yes, that was - it's not really a change, I think we've just come to the end of that cycle.

Okay. Thank you.

I think - would we get back to opening, we're in every state. We have decent location penetration.

Are there some opportunities, yes, but I think it's going to be less of a purposeful effort and more, as I mentioned earlier, kind of opportunistic where we have the talent lining up with the opportunity.

Got it, thanks.

Good morning. Just a question on long-term care, especially on the rate increases.

There is a reason article by Moody's [ph]. Moody is talking about potentially maybe a little less accommodative regulation - from the regulators.

And I was just - and you've talked about your success rate which has been higher than your 40%. But do you see a change in terms of the sentiments from the regulators from a year ago versus where you are right now?

Thanks, Humphrey, this is Ed. I would say the short answer is yes but that's why we factored in a 40% assumed success factor with this round of rate increases where our prior round was just north of 60% success factor.

So we did expect that state insurance departments were being inundated with rate increase request. That was slowing down the process and in certain places making it more difficult to get full rate increases approved.

So all considered in our 40% assumption.

Okay, thank you. And then maybe a question for Scott, in terms of bankers, third-party policies and getting a fee income in that regard, how much type of potential and that particular type of activities.

And can you put potentially add more product line ups from third-parties through your Bank's channel.

Yes, Humphrey it's a good question. The answer is, we will continue to assess what the middle market consumer needs.

And will then assess whether or not it makes sense for us to - as manufacture to offer that product or to go source it through a certain third party. So I think the answer - the short answer to your question is yes, there are likely other opportunities.

However we're careful because it is a matter of shelf space it's a matter of making sure it's right product that meets the consumer needs. And it's also something that the agency force Chin fit into the portfolio.

So we look carefully at other opportunities and we do have a little with ACA plants, that might be an area of future expansion, and we'll continue to keep an eye on those consumer needs and other opportunities for expanding third-party distribution or developing products on our own. Another good example of third-party activity that isn't factored into our results yet but ultimately in our reporting we will reflect this, and that's the activity of our financial advisors.

So our financial advisors, are by definition selling third-party products and that's currently not reflected in our activity but we expect to reflect in the future.

Okay, thanks for the color. And if I can may sneak one more in.

I know some Japanese life insurers talked about buying nursing home on long-term care facility as part of the investment strategy. And AIG talked about how you must stay into nursing home facilities in the U.S.

as well. Since you've talk about finding ways to utilize your non-live NOLs, have you considered kind of looking into buying sort of nursing home facilities or investing in that area to - for one as a natural hedge to your long-term care position, and second of all, to generate some non-life earnings.

Thanks for the question Humphrey. I would say sad about it but in keeping with - where do we have the right and ability to compete, we don't see that as being a place where we've got enough expertise to own and operate facilities like this.

So that would not be something that is in our current screen of M&A. On the margin if there is an investment, a bond that is related to one of these types of properties, certainly it would be considered but more on its investment merits like other industries.

Okay, thank you.

Good morning. Following up on some earlier questions, you mentioned an expected natural increase in the long-term care benefit ratio overtime.

Is there any additional sense you can provide on maybe the order of magnitude or pace of this expected increase? I guess I'm just trying to get a sense of how to think about the pieces for the expected GAAP earnings trajectory for the long-term care business considering natural run-offs, this change in the benefit ratio and price increases.

So any commentary would be helpful. Thanks.

Sure Dan, this is Erik. So it's - I would categorize it as sort of a slow process and I'm build to something which would probably be into the high 80's, low 90's over several years, perhaps six to eight to ten years.

Little difficult to pinpoint exactly what that timeline is going to be but that's through the order of magnitude. And it's in keeping with sort of the rationale for why we're building a future loss reserve is because we have profits right now, and we'll have them again for the next six to eight years and one of those periods will be followed by losses.

So we've build a FLR now and then reduce it once we get into that inflexion period. Is that helpful?

Yes, great, thank you.

And maybe I'll add to that, of course that's I will say a status quote that sales are not materially different than the levels we have now or the mix of the long-term care sales aren't materially different. And it's also without any future rate increases or transactions.

Great, thank you. And maybe switching gears a little bit, just on to the expenses you've been incurring related to investments for growth and the Bankers and Washington National units, I wanted to see if you could provide any additional color on the types of investments you're making, and maybe any sense of the magnitude of these investments and how much they are suppressing near term earnings.

And then related to that what type of payback you would expect from these investments down the road?

Sure Dan, it's Erik again. So we have been - as Scott mentioned in his remarks, we [ph] have been investing in growth and productivity initiatives.

For a longer period of time like Colonial Penn in more recent periods. Specifically on Bankers Life and to some extent Washington National, what's going on right now with Banker's Life is really a couple of things which is adding to our expenses.

First is a roll out of salesforce nationwide to our career agency force. That is essentially a CRM system that they field force will use to manage a lead manage a lead, manage clients etcetera.

So that is being rolled out right now and there will be an ongoing cost associated with that. The second thing that's going on right now is that we are building out and staffing up our broker dealer as Scott mentioned, our own in-house broker dealer and registered investment advisor eventually.

So that will add expense and has added expense and will continue in the future. Order of magnitude we called about $4 million of incremental expense.

Not all of that was related to these growth and productivity initiatives. I'd say roughly half were.

In terms of the payback, yes we would expect those expenses to continue in the future. However, what you should see is increased agent productivity which should lead to increased sales, and then eventually increased income as we move the financial advisers that Scott spoke about over our own platform and generate incremental feed income.

Very helpful. Thank you.

Good morning. Ed, I was wondering if you could talk about a broader discussion on what you're consider with long-term care risk transfer.

What are the opportunities out there as we see them. And when you think about kind of the gambit of things that you might undertake with most of them be capital consumers or have you set aside some level of capital in your overall risk management framework that would actually be released?

Tom, thanks. The one way that we think of it - describe it is, we would expect of options and what I mean by that is that from the different potential corner of parties interested reinsurers, we definitely see transactions being reinsurance, co-insurance or potentially of funds withheld type of arrangement.

We are still very much committed to long-term care through Bankers Life career agents, it meets important needs in the middle market and it serves them, we believe continuing to sell the product is important. With that we would retain administration and so the reinsurance construct is what we envision.

In that the reason I say a smorgasbord [ph] is that you think about - first of all, one slice is the vintages of issue years. And some third-party's are interested in the most seasoned business.

So those could be issues in the 70's and 80's, 1970s or 1980s with a much higher attained age, pretty much the claim, mortality lapse dynamics have been demonstrated over multiple years and that provides certain counterparties something they are interested in. That said, those products are those that cohort would have the lower durations or the least number of years of duration due to their high attained age, so there are other parties that are looking for long durations and the longest would be the more recent issues that way.

Also there is different types of coverages, we have comprehensive home healthcare, nursing home care, and again different counterparties have different interests there. And then later on are still selling new business, some parties as our GA has been a new business reinsure for us since 2008, they continue to be a reinsurer and are interested in new business.

So as we look at that, we understand to accomplish our objectives, we're going to have to have not just more new business or more recent business, be the only part of any transaction. We're going to need to have some of the policies that are issued prior to 2000 in the mix because they have the highest average reserves, they are the ones that are having the accruals for future loss reserves on them.

So they will be in part in the equation. So hopefully that helps to give you some color there.

Does that answer your question?

Yes, that's helpful Ed. And when you think about overall capital planning framework, are you setting aside - do you have a large budget in terms of your capital that you're setting aside, the potential to be able to reinsure some of the pre-2000 book?

I assume there would be a cost associated with it.

No, fair question and sorry I didn't answer that right away. First, I mean our capital in the insurance companies with 4.40% RBC is above what we would expect to carry in the longer term environment.

We consciously did build Bankers Life RBC north of 400% recognizing that's where the long-term care business is and we have been for some time caring excess liquidity at the holding company. That said, what charge if any we have in the magnitude of any charge or any cash outlay will depend quite a bit on what part of the smorgasbord [ph] we're picking from because combination of different issue years, different policy types could have a mix of policies that are accruing a future loss reserves.

And those that aren't so that you know that could help mitigate any potential cash outlay or charge.

Okay, that's helpful. And then my only other question is on - and I apologize if you referenced this earlier.

Your energy portfolio - are you comfortable with your exposure there considering - I think you might have trim some of it this quarter but how are you thinking about that overall?

Good morning, this is Erik Johnson [ph]. I just knew someone was going to ask about this today, notwithstanding that I didn't write any notes down but I mean obviously management teams are expecting oil prices to stay lower for longer, lot of folks out there on cutting costs, reducing capital spending, folks joining programs on more profitable acreage.

Looking very hard at 2016 CapEx announcement by producers feeling lower all the time, rig markets under a lot of pressure, and certainly in this area selectivity is critical, I think we are exhibiting a lot of that this year. We've turned over probably about 25% to 30% of our energy portfolio and most of that's been in up end quality direction.

And I feel we've made some good choices that will sustain themselves, notwithstanding a lower for a longer environment. We're not really - our strategy is not to play for time and hope that the oil prices will go back up in three months or six months.

It would have strong hands over a sustained period and clip a good income. Certainly the story's not over, we still have continued work to do and when you see spreads widen as much as they did, for example, during the third quarter and also they'll be as high as it was.

We're going to have to deal with that. So I'm not sounding at all clear about what I am saying is that I think we're in a good position over the long term to do well in this area.

Go ahead.

No please, I'm done there.

I just wanted to follow-up the 25% to 30% turnover. Did you do most of that in the last quarter two or you've been doing that for a longer period of time?

This is something we've been talking about and acting on throughout the whole - pretty much throughout the whole year, pretty steadily and I think it probably continues through the fourth quarter. It's a volatile sector and risks and opportunities unveil themselves over as we speak, and so I think this will continue and certainly it's reflected in the gains and losses through the first three quarters.

And I think that pattern will persist through the fourth quarter.

Okay, thanks.

You're welcome.

Operator, are there any other questions?

All right. Thank you and thanks to everyone on the call for your interest.

And again, I apologize for some of the cut-off question.